Ubiquitinated target protein

"Ubiquitinated target protein" is not a specific protein or canonical therapeutic target, but rather a general term for any protein that has been post-translationally modified by the covalent attachment of one or more ubiquitin molecules through a process termed ubiquitination[2][3][5]. This process involves a well-characterized enzymatic cascade utilizing E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases, which ultimately attach ubiquitin to lysine or other residues on the substrate protein[1][4][5]. Ubiquitination serves to mark proteins for various cellular fates: most classically, K48-linked polyubiquitin chains target proteins for degradation by the 26S proteasome, while other linkage types (e.g., K63, M1) control non-proteolytic processes such as signaling, DNA repair, and trafficking[3][4][5][1]. Ubiquitinated proteins are implicated in major physiological and pathological processes, including cell cycle regulation, apoptosis, immune signaling, and diseases such as cancer, neurodegeneration, and infection[2][3][4][5]. However, because "ubiquitinated target protein" refers to any protein modified by ubiquitin rather than a defined gene product or receptor, it is not considered a canonical therapeutic target or a molecule with its own abbreviation, aliases, or direct drugs. Drugs currently in development target components of the ubiquitin system (such as E3 ligases or the proteasome), but not ubiquitinated target proteins generically[2][3]. **Reasoning for is_incorrect = true:** - "Ubiquitinated target protein" is a generic descriptor, not the name of a single molecular entity, protein, or receptor. - It does not refer to a specific gene, protein, or structure, but to any substrate marked by ubiquitination[2][3][5]. - As a result, it cannot be mapped to specific aliases, a canonical name or symbol, or a definitive list of interacting drugs, mechanisms of action, or biomarkers. - For structured annotation, it is necessary to specify the particular protein or enzyme that is ubiquitinated (such as "p53 (ubiquitinated form)" or "Cyclin D1 (ubiquitinated)"). For these reasons, "Ubiquitinated target protein" should not be annotated as a canonical therapeutic target or molecular entity.